You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

OGCTs, P16 , Ki67 , IHC

Showing 1 - 25 of 918
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Protein P16 Expression in Ovarian Germ Cell Tumors.

Completed
Has Results
  • Ovarian Neoplasms
  • +2 more
  • p16INK4a Recombinant Rabbit Monoclonal Antibody (RM267)
  • Ki67 antibody (DAKO) for malignant cases only
  • Assiut, Egypt
    Assiut University
Aug 12, 2021

Cervix Cancer, HPV Testing, Postmenopausal Women Trial in Randers (cytology, p16/ki67 dual stain cytology (DS), extended

Recruiting
  • Cervix Cancer
  • +2 more
  • cytology, p16/ki67 dual stain cytology (DS), extended genotyping, DNA methylation, viral load,
  • Randers, Central Denmark Region, Denmark
    Department of Pathology
Feb 3, 2023

CZ Using the Detection of HPV DNA and CINtec Plus

Completed
  • Algorithm for Cervix Carcinoma Screening
  • HPV DNA test with selective HPV 16/18 genotyping (cobas® 4800 HPV Test, Roche)
  • +2 more
  • Praha, Czech Republic, Czechia
    Aeskulab Patologie, ks
Oct 11, 2022

Wilms Tumor, Relapse, Death Trial in Mansoura (P53, Ki67 and Cyclin A IHC.)

Unknown status
  • Wilms Tumor
  • +2 more
  • P53, Ki67 and Cyclin A IHC.
  • Mansoura, Dakahlia, Egypt
    Mansoura Urology and Nephrology Center. Faculty of Medicine, Man
Feb 16, 2021

CA-IX, p16, Proliferative Markers, and HPV in Diagnosing

Active, not recruiting
  • Atypical Endometrial Hyperplasia
  • +2 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Tucson, Arizona
  • +162 more
Oct 27, 2022

Breast Cancer Trial in Worldwide (Amcenestrant (SAR439859), Letrozole)

Terminated
Has Results
  • Breast Cancer
  • Tucson, Arizona
  • +31 more
Jun 27, 2022

Breast Cancer Trial in New York (core needle biopsy, blood draw)

Recruiting
  • Breast Cancer
  • core needle biopsy
  • blood draw
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Nov 9, 2023

Metastatic Breast Cancer Trial in Dallas (DB-1303, Capecitabine, Paclitaxel)

Not yet recruiting
  • Metastatic Breast Cancer
  • Dallas, Texas
    Texas Oncology - Baylor Charles A. Sammons Cancer Center
Aug 25, 2023

Galectin-3 in Papillary Thyroid Carcinoma

Not yet recruiting
  • Galactin 3-thyroid Carcinoma
    • (no location specified)
    Jan 26, 2023

    Menstrual Cycle, PAM50, Ki67 on Treatment Decisions in HR+ and

    Recruiting
    • Hormone Receptor Positive HER-2 Negative Breast Cancer
      • Tuebingen, Germany
        Department of Women's Health
      Jun 1, 2023

      HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma Trial (SHR-A1811, Ramucirumab / Paclitaxel/

      Not yet recruiting
      • HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
      • SHR-A1811
      • Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan
      • (no location specified)
      Nov 6, 2023

      Locoregional Recurrence of Breast Cancer

      Not yet recruiting
      • Locoregional Recurrence
        • (no location specified)
        Aug 4, 2023

        Bone Diseases, Pain Trial run by the NIDCR (Denosumab)

        Active, not recruiting
        • Bone Diseases
        • Pain
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Feb 17, 2022

        Oropharynx Cancer Trial in Philadelphia (Radiation therapy (5 days for 7 weeks), Radiation therapy (5 days for 6 weeks),

        Recruiting
        • Oropharynx Cancer
        • Radiation therapy (5 days for 7 weeks)
        • +2 more
        • Philadelphia, Pennsylvania
          Fox Chase Cancer Center
        Apr 5, 2023

        Ovarian Carcinoma Trial in Israel, United States (Denosumab, Salpingo-Oophorectomy)

        Terminated
        Has Results
        • Ovarian Carcinoma
        • Denosumab
        • Salpingo-Oophorectomy
        • Boston, Massachusetts
        • +5 more
        May 23, 2022

        Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Ductal Carcinoma In Situ Trial in

        Not yet recruiting
        • Anatomic Stage I Breast Cancer AJCC v8
        • +3 more
        • Biospecimen Collection
        • +4 more
        • Houston, Texas
        • +2 more
        Aug 17, 2022

        Oropharyngeal Cancer, Squamous Cell Carcinoma of the Oropharynx Trial in Ann Arbor (procedure, combination product, other,

        Recruiting
        • Oropharyngeal Cancer
        • Squamous Cell Carcinoma of the Oropharynx
        • Surgery
        • +3 more
        • Ann Arbor, Michigan
          University of Michigan Rogel Cancer Center
        May 30, 2023

        Breast Cancer, Breast Cancer, Early-Onset Trial (Giredestrant, Tamoxifen)

        Not yet recruiting
        • Breast Cancer
        • Breast Cancer, Early-Onset
        • (no location specified)
        Jan 18, 2023

        Primary Sjögren Syndrome Trial (68Ga-P16-093)

        Not yet recruiting
        • Primary Sjögren Syndrome
        • (no location specified)
        Sep 19, 2023

        Breast Cancer Invasive, Hormone-receptor-positive Breast Cancer, HER2 Low Breast Carcinoma Trial in Guangzhou (Pyrotinib,

        Not yet recruiting
        • Breast Cancer Invasive
        • +3 more
        • Pyrotinib, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
        • Placebo, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
        • Guangzhou, Guangdong, China
          Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
        Nov 17, 2023

        Colon Cancer Trial in Lexington (TVB-2640, Placebo)

        Recruiting
        • Colon Cancer
        • Lexington, Kentucky
          University of Kentucky
        Jan 18, 2023

        Brain Tumor, Brain Cancer Trial in Taipei (mesoscale nonlinear optical microscope)

        Recruiting
        • Brain Tumor
        • Brain Cancer
        • mesoscale nonlinear optical microscope
        • Taipei, Taiwan
          Department of Surgery, National Taiwan University Hospital and C
        Jul 4, 2023

        HER2/Neu Negative, Progesterone Receptor Negative, Progesterone Receptor Positive Trial in United States (procedure, drug,

        Active, not recruiting
        • HER2/Neu Negative
        • +3 more
        • Computed Tomography
        • +3 more
        • Birmingham, Alabama
        • +24 more
        Jan 27, 2023

        HER2-low Unresectable and/or Metastatic Breast Cancer in Russia

        Recruiting
        • Breast Cancer
          • Arkhangelsk, Russian Federation
          • +41 more
          Jun 28, 2023

          Breast Cancer Trial (Trastuzumab Deruxtecan)

          Not yet recruiting
          • Breast Cancer
          • Trastuzumab Deruxtecan
          • (no location specified)
          Jul 10, 2023